Skip to main content
. 2018 Dec 12;22(3):406–410. doi: 10.1038/s41391-018-0114-1

Fig. 1.

Fig. 1

Kaplan–Meier distant metastasis-free survival curves across BRCA1/2 mutation status (cohort 1, N = 927). The figure depicts time to distant metastasis as survival estimate for the categories of patients based on BRCA1/2 mutation status. a Wild-type BRCA1/2 and benign/likely benign mutations in BRCA1/2; b variants of unknown significance in BRCA1/2; c pathogenic mutations in BRCA1/2; d metastasis